Search
Displaying results 191 to 200 of 673.
Hospital germs have their flaws too
The pathogen Pseudomonas aeruginosa (P. aeruginosa) uses a variety of tricks to perfectly adapt to its environment. Pseudomonas bacteria can colonise and proliferate in virtually any environment, including the lungs, eyes, urinary tract, an open wound or an implant.…
New therapeutic approaches for necrotising fasciitis
Streptococcus pyogenes is a very wide-spread Streptococcus species known to be the pathogen eliciting bacterial angina, which is also known as tonsillitis. Scarlet fever and middle ear infections can also be caused by this bacterium. Pathogens of the species…
Herrenhausen Symposium on Individualized Infection Medicine
New and recurrent infectious diseases, combined with steadily increasing resistance to antibiotics and the global mobility of people, create enormous new challenges for modern medicine. Consequently, therapies must combine maximum efficacy with minimum toxicity.…
Federal Minister of Research Anja Karliczek and State Minister Björn Thümler visit Infection Research Centres in Hannover
Federal Minister of Research Anja Karliczek and State Minister Björn Thümler today caught up with the current challenges and innovative approaches in modern infection research in Lower Saxony. They visited the HZI-operated study centre of the NAKO health study in…
Empowering scientists to make a difference in translational medicine
One highlight of the course was the lecture from Rodger Novak, the co-founder and president of CRISPR Therapeutics who shared the story of the development of the company CRISPR Therapeutics and stressed the importance of credibility for start-ups. As most participants…
Machine learning flags emerging pathogens
As the cost of genomic sequencing falls, scientists around the world are using genetics to better understand the bacteria causing infections, how diseases spread, how bacteria gain resistance to drugs, and which strains of bacteria may cause outbreaks. However, current…
Inhoffen Medal 2018 awarded to pharmacist Rolf Müller
The Inhoffen Medal, which is awarded by the sponsors' association Friends of the HZI, is considered to be one of the most prestigious awards in the field of natural product chemistry and is endowed with €5000. The award is presented in the scope of the Inhoffen Lecture,…
Making sure that antibiotics will still be effective in the future
The WASA project runs continued education seminars which address topics such as "Guideline-based antibiotics management of upper and lower airway and urinary tract infections by general practitioners". The training sessions were developed by the Hygienenetzwerk…
Potential new drugs from previously unknown tropical fungus
Fungi are playing a crucial role in the search for new active compounds: As a rich source of metabolic products with selective biological activity, they can be used for the development of new drugs. The so-called mycobiota of tropical countries offers a great potential…
Medicine Maker honours HIPS researcher
Lehr is the head of the "Drug Delivery" department at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). His research focuses on the tailor-made transport of medications through the biological barriers of the body to their site of action. The "Top 100"…